MONTEFIORE MEDICAL CENTER
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1884-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.montefiore.org
Montefiore Opioid and Pain Study
Completed
- Conditions
- Acute Pain
- First Posted Date
- 2017-12-18
- Last Posted Date
- 2022-02-17
- Lead Sponsor
- Montefiore Medical Center
- Target Recruit Count
- 462
- Registration Number
- NCT03375645
- Locations
- 🇺🇸
Montefiore Medical Center, Bronx, New York, United States
Liposomal Bupivacaine in Bariatric Surgery
Phase 2
Completed
- Conditions
- Bariatric Surgery Analgesia
- Interventions
- Drug: Liposomal Bupivacaine TAP block
- First Posted Date
- 2017-12-14
- Last Posted Date
- 2019-11-04
- Lead Sponsor
- Montefiore Medical Center
- Target Recruit Count
- 219
- Registration Number
- NCT03373591
- Locations
- 🇺🇸
Montefiore Medical Center, Bronx, New York, United States
Use of Perioperative Antibiotics in Endoscopic Sinus Surgery
Phase 4
Suspended
- Conditions
- Chronic Sinus Infection
- Interventions
- Drug: Amoxi Clavulanate
- First Posted Date
- 2017-12-12
- Last Posted Date
- 2022-02-07
- Lead Sponsor
- Montefiore Medical Center
- Target Recruit Count
- 400
- Registration Number
- NCT03369717
- Locations
- 🇺🇸
Montefiore Medical Center, Bronx, New York, United States
1% Chloroprocaine(PF) vs. Bupivacaine Spinals
Phase 2
Completed
- Conditions
- Return of Motor and Sensory BlockadeAnesthesia, SpinalDecrease Discharge Time Status Post Hemorrhoidectomy
- Interventions
- First Posted Date
- 2017-10-30
- Last Posted Date
- 2025-02-28
- Lead Sponsor
- Montefiore Medical Center
- Target Recruit Count
- 110
- Registration Number
- NCT03324984
- Locations
- 🇺🇸
Montefiore Medical Center, Bronx, New York, United States
Budesonide for Immunosuppression After Liver Transplantation to Reduce Side Effects
Phase 4
Withdrawn
- Conditions
- Acute Cellular Graft RejectionLiver Transplant Rejection
- Interventions
- First Posted Date
- 2017-10-19
- Last Posted Date
- 2019-09-23
- Lead Sponsor
- Montefiore Medical Center
- Registration Number
- NCT03315052
0.25% Bupivacaine Versus a Mixture of 0.25% Bupivacaine and 1.3 % Liposomal Bupivacaine in Patients Undergoing Tka
- First Posted Date
- 2017-10-06
- Last Posted Date
- 2020-03-20
- Lead Sponsor
- Montefiore Medical Center
- Target Recruit Count
- 25
- Registration Number
- NCT03303794
- Locations
- 🇺🇸
Montefiore Hutchinson Campus, Bronx, New York, United States
Intravenous Lidocaine Randomized Comparative Effectiveness Trial
- First Posted Date
- 2017-10-03
- Last Posted Date
- 2020-08-10
- Lead Sponsor
- Montefiore Medical Center
- Target Recruit Count
- 154
- Registration Number
- NCT03300674
- Locations
- 🇺🇸
Montefiore Medical Center, Bronx, New York, United States
A National Registry For Patients With Hidradenitis Suppurativa
Completed
- Conditions
- Hidradenitis Suppurativa
- First Posted Date
- 2017-09-21
- Last Posted Date
- 2023-03-03
- Lead Sponsor
- Montefiore Medical Center
- Target Recruit Count
- 400
- Registration Number
- NCT03289585
- Locations
- 🇺🇸
Montefiore Medical Center, Bronx, New York, United States
Impact of Hidradenitis Suppurativa on Quality of Life Functions
Completed
- Conditions
- Quality of LifeHidradenitis Suppurativa
- First Posted Date
- 2017-09-20
- Last Posted Date
- 2023-01-20
- Lead Sponsor
- Montefiore Medical Center
- Target Recruit Count
- 400
- Registration Number
- NCT03288337
- Locations
- 🇺🇸
Montefiore Medical Center, Bronx, New York, United States
The Impact of Point-of-Care Ultrasound
Completed
- Conditions
- UltrasoundShock
- Interventions
- Diagnostic Test: Ultrasound
- First Posted Date
- 2017-09-08
- Last Posted Date
- 2017-09-08
- Lead Sponsor
- Montefiore Medical Center
- Target Recruit Count
- 112
- Registration Number
- NCT03276364
© Copyright 2025. All Rights Reserved by MedPath